Aligos Therapeutics Inc (ALGS) — Long-term Investment Intensity
Aligos Therapeutics Inc (ALGS) has a Long-term Investment Intensity of 6.4% as of December 2021. Long-term investments of $15.11 Million represent 6.4% of total assets of $235.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ALGS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aligos Therapeutics Inc Long-term Investment Intensity (2019–2021)
This chart shows how Aligos Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2019 to 2021. As of December 2021, the intensity stands at 6.4%, reflecting long-term investments of $15.11 Million against total assets of $235.37 Million USD. Explore Aligos Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Aligos Therapeutics Inc (2019–2021)
The table below presents the year-by-year Long-term Investment Intensity for Aligos Therapeutics Inc from 2019 to 2021, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Aligos Therapeutics Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 6.4% | $15.11 Million | $235.37 Million | ▼ -0.4 pp |
| 2019 | 6.8% | $10.02 Million | $146.52 Million | — |